Prostate cancer organoids pave way towards precision oncology
Scientists develop organoid models of neuroendocrine prostate cancer to study EZH2 inhibitors and reveal a potential new target. Researchers at... Read More
Scientists develop organoid models of neuroendocrine prostate cancer to study EZH2 inhibitors and reveal a potential new target. Researchers at... Read More
Scientists have discovered that cells lacking the tumour-suppressor protein PTEN – a feature of many cancers – are particularly vulnerable... Read More
Researchers have demonstrated that genetic variations driving prostate cancer determine the composition of the immune cells that have been found... Read More
Researchers identify a pathway that causes tumour acceleration in metastatic prostate cancer cells. Read more.